Home » Nasal Drug Delivery Technology Market

Nasal Drug Delivery Technology Market By Dosage form (Nasal Spray, Nasal Drop, Nasal Gel, Nasal Powder) By Container type (Pressurized Containers, Non-pressurized Containers)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 20346 | Report Format : PDF

Actionable Insights Delivered – nasal drug delivery technology Market Size

Positioned with a USD 72.5 billion valuation in 2022, the nasal drug delivery technology Market asserted its global eminence. Set to scale to USD 123.4 billion by 2030, the market’s remarkable Compound Annual Growth Rate (CAGR) of 7.90% (2022-2030) underscores its strategic growth trajectory.

Key Highlights of the Report

The global nasal drug delivery technology market is segmented by dosage form, container type, therapeutic application, distribution channel, and region. Nasal spray drug delivery technology is the most popular in the dosage form, while nasal drop holds the maximum CAGR. In addition, non-pressurized containers are the dominating segment. While Rhinitis is the most commonly used therapeutic application, retail pharmacies account for the maximum share in the forecast period, with North America leading the market growth.

The global nasal drug delivery technology market has several drivers, including the rise in patient preference for nasal drug delivery due to its simplicity and superior efficacy and the rising acceptance of self-administration practices. Intranasal drug delivery is one of the most popular drug delivery methods among patients and medical professionals. This is primarily explained by the fact that this distribution method is non-invasive and that drugs are more readily absorbed when administered via the nasal route. However, the market faces significant challenges, such as histopathological toxicity or a smaller absorption region than orally delivered drugs.

Nonetheless, the global Nasal drug delivery technology market offers significant growth opportunities, including technological developments and the introduction of sophisticated nasal medication delivery devices.

What Are The Main Drivers Of The Global Nasal drug delivery technology Market?

The global nasal drug delivery technology market is driven by several factors, including the rising prevalence of chronic diseases and the increasing inclination for an alternate drug administration method that provides improved patient comfort.

What Are The Major Challenges Faced By The Global Nasal drug delivery technology Market?

The global nasal drug delivery technology market faces several challenges, including histopathological toxicity or a smaller absorption region than orally delivered drugs.

What Are The Growth Opportunities In The Global Nasal drug delivery technology Market?

The global nasal drug delivery technology market offers significant growth opportunities, including technological developments and the introduction of sophisticated nasal medication delivery devices.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Executive Summary

Overview of the Global Nasal drug delivery technology Market

The global nasal drug delivery technology market has steadily grown in recent years, driven by chronic diseases are more common than ever before, and their prevalence is inclination for an alternate drug administration method that provides improved patient comfort. The market is distinguished by a vast array of form outlooks, container types, therapeutic applications, and distribution channels catering to diverse consumer preferences.

Market Definition

The nasal drug delivery device offers direct access to systemic circulation as an alternative to invasive administrations. The most frequent and favored drug delivery route in treating pain is treatment of acute migraines, allergic and non-allergic rhinitis, and nasal congestion caused by sinusitis, the common cold, or rhinitis. Nasal drug delivery methods are typically employed when a quick start of action is desired or when other routes of administration are unsuccessful. Nasal drug delivery is the preferred method for needle-free vaccinations and systemic drug delivery. Inhalers, droppers, spray pumps, nebulizers, or atomizers can all be used to provide liquid nasal solutions.

Market Insights

  • The global demand for nasal drug delivery technology was valued at USD 72.5 Billion in 2022 and is expected to reach USD 123.4 Billion in 2030, growing at a CAGR of 7.90% between 2023 and 2030.
  • The nasal spray is the leading segment by Form Outlook and held over 43% share in terms of value in 2022.
  • The non-pressurized containers segment governs the demand for nasal drug delivery technology globally, holding a massive share of over 80% in 2022, and is expected to grow at a rapid CAGR.
  • The asthma segment is expected to post the highest CAGR during the forecast period. Whereas, Rhinitis segment is dominating the market with the highest revenue.
  • The hospital pharmacies segment is expected to post the highest CAGR during the forecast period.
  • North America is fueling the growth of the nasal drug delivery technology industry with over one-third share in 2022, while Asia Pacific and Europe collectively account for just under 50% share in 2022. Europe held over 22% share in 2022.
  • The prevalence of asthma and chronic obstructive lung disease is rising, and early intervention strategies are frequently employed. At the same time, histopathological toxicity or a smaller absorption region than orally delivered drugs are the main restraints.
  • Technological developments and the introduction of sophisticated nasal medication delivery devices are the major opportunities in the market.

Segmentation by Dosage form

  • The nasal spray is the leading segment by Form Outlook and held over 43% share in terms of value in 2022.
  • Nasal Drop holds the highest CAGR during the forecast period.

Segmentation by Container type

  • The non-pressurized containers segment governs the demand for nasal drug delivery technology in the world, holding a massive share of over 80% in 2022, and is also expected to grow at a rapid CAGR.

Segmentation by Therapeutic application

  • The Rhinitis segment is leading the market share with over 30% share in 2022.
  • Asthma holds the highest CAGR during the forecast period.

Segmentation by Distribution channel

  • The retail pharmacies segment is leading the market share with over 30% share in 2022.

Segmentation by Region

  • North America is fueling the growth of the nasal drug delivery technology industry with over one-third share in 2022.
  • Asia Pacific and Europe collectively account for just under 50% share in 2022, with Europe holding over 22% share in the same year.
  • The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for nasal drug delivery technology.

The increasing demand for nasal drug delivery technology can be ascribed to an increase in the incidence of chronic diseases and an increase in inclination for an alternate drug administration method that provides improved patient comfort. However, the market is restrained by histopathological toxicity or a smaller absorption region than with orally delivered drugs.

The United States is one of North America’s largest markets for nasal drug delivery technology, with a significant market share. Asthma and chronic obstructive lung disease are rising, and early intervention strategies are frequently employed. As the third leading cause of death, chronic obstructive pulmonary illness in the United States. As a result, the prevalence of COPD may be driving up the use of nasal medication delivery systems.

China is also a major market for nasal drug delivery technology in the Asia Pacific region, with a significant market share. Due to increasing R&D spending, a rise in the prevalence of chronic diseases, and more public awareness. Growth potential is created by the expanding patient population and significant healthcare providers in quickly developing nations like China and India. Government spending is also driving up healthcare prices in the Asia Pacific region.

Overall, the increasing demand for nasal drug delivery technology can be attributed to the rising prevalence of chronic diseases and the increasing inclination for an alternate drug administration method that provides improved patient comfort.

While the nasal drug delivery technology market is growing, it faces challenges from histopathological toxicity or a smaller absorption region than with orally delivered drugs. Manufacturers are innovating and Form Outlooking partnerships to stay competitive.

Nasal Drug Delivery Technology Market

Expansion of Chronic Respiratory Conditions

Over the past few years, respiratory infections have become more common. Sudden climate change, increasing pollution, and a reduction in immunity brought on by a sedentary lifestyle are some of the key contributors to the rise in these illnesses and respiratory infections. COPD, asthma, pneumoconiosis, pulmonary sarcoidosis, and interstitial pulmonary disease are examples of chronic respiratory illnesses. These illnesses have a big socioeconomic impact on governments and society. Acute lower respiratory tract infections have regularly ranked among the top three causes of death and disability in children and adults for a very long time. Over 80% of all illnesses are respiratory-related in underdeveloped nations. In 2022, 200 million people worldwide suffered from COPD. COPD has a greater incidence rate when compared to important lifestyle disorders, including hypertension, hypercholesterolemia, and others. Over the past 20 years, the number of persons with chronic respiratory ailments has increased by around 40%. Around the world, asthma in children is also growing increasingly common.

Certain Limitations Associated with The Use of Nasal Drug Delivery Technology

In addition to headaches, coughing, swelling (inflammation) of the nasal passages, an increased risk of sinus infections, and rarely, tears in the membranes of the nostrils, nasal spray misuse can also result in migraines. The development of the market for nasal drug delivery technology may also be hindered shortly by regulatory obstacles.

Technology Development to Accelerate Industry Growth

In the upcoming years, technological developments and the introduction of sophisticated nasal medication delivery devices are predicted to accelerate market growth. Due to their capacity to allow consumers to consume more of the product from the same container in a bigger volume and at a lower cost than single-dose nasal spray bottles, multidose nasal devices are becoming increasingly popular. The market for nasal medication delivery technologies is anticipated to grow throughout the forecast period due to new product development and approvals in multidose nasal devices. For instance, Aptar Pharma debuted APF Futurity, the first metal-free, recyclable multidose nasal spray pump for nasal saline and other over-the-counter pharmaceutical goods.

Due To The Convenience Of Nasal Sprays

Nasal drug administration has emerged as one of the most practical drug delivery methods. The market is anticipated to grow because patient outcomes have improved due to making medications and therapies more available to patients, making them easier to use, and enabling their access to the care they need. Other elements that influence market expansion include higher R&D expenditures and plans to create novel nasal pharmaceutical therapy, particularly for ailments unrelated to the respiratory system. To effectively treat migraines, Pfizer, for instance, introduced the nasal spray Zavzpret (zavegepant) in 2023. Similarly, it was asserted to be beneficial for Alzheimer’s patients. An anti-nasal Alzheimer’s spray is expected to undergo clinical testing in 2022, according to research done by Osaka City University.

Competitive Landscape

Key Players

The global nasal drug delivery technology market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

  • GlaxoSmithKline PLC
  • AstraZeneca PLC
  • Pfizer, Inc.
  • OptiNose, Inc.
  • Becton
  • Dickinson and Company
  • Promius Pharma, LLC
  • Cadila Pharmaceuticals Ltd.
  • B.F. Ascher & Company, Inc.
  • PendoPharm, Inc.
  • Douglas Pharmaceuticals Ltd.
  • ENT Technologies Pty. Ltd.
  • NAVEH Pharma Ltd.

These companies focus on product innovation, expanding their Distribution channels, and mergers and acquisitions to stay ahead in the market.

The major players in the global nasal drug delivery technology market constantly strive to stay ahead by introducing new products and innovations.

The launch of the generic form of Narcan1 (naloxone hydrochloride nasal spray) was announced by The American branch of Teva Pharmaceutical Industries Ltd. is called Teva Pharmaceuticals., on December 22, 2021. A prescription drug called naloxone hydrochloride nasal spray is employed to treat a crisis involving an opioid, such as an overdose or a potential overdose, with symptoms including breathing difficulties or an inability to respond.

The BHM Anti-Viral Nasal Spray, an easy-to-use nasal device with a special patented formulation called Norizite, was launched in Singapore on April 28, 2022, according to a press release from Birmingham Biotech, a company that provides a wide range of in vitro diagnostic solutions, medical devices, and equipment.

In 2019, AptarGroup, Inc. purchased Noble International, a leader in patient onboarding programs and prefilled syringes, autoinjectors, breathing devices, and on-body devices for drug delivery training.

Summary of Key Findings

  • The rising prevalence of chronic diseases and the increasing inclination for an alternate drug administration method that provides improved patient comfort drive market growth.
  • Market segmented by dosage form, container type, therapeutic application, distribution channel, and region.
  • Nasal spray nasal drug delivery technology is the most popular segment.
  • Non-pressurized containers are most commonly used for container-type outlooks.
  • Rhinitis is most commonly used for therapeutic application.
  • Retail pharmacies are most commonly used for distribution channels.
  • North America is leading market growth; the market is highly competitive with key players including GlaxoSmithKline PLC; AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson, and Company; Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company, Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; NAVEH Pharma Ltd.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  • Positive outlook for the global nasal drug delivery technology market with significant growth potential in the North American region
  • Technological developments and the introduction of sophisticated nasal medication delivery devices to drive growth
  • Challenges from histopathological toxicity or a smaller absorption region than with orally delivered drugs.
  • Key players to focus on product innovation, expanding market reach and maintaining competitive pricing to stay ahead in the market.

Segmentation

  • By Dosage form
    • Nasal Spray
    • Nasal Drop
    • Nasal Gel
    • Nasal Powder
  • By Container type
    • Pressurized Containers
    • Non-pressurized Containers
  • By Therapeutic application
    • Nasal Congestion
    • Rhinitis
    • Asthma
    • Others
  • By Distribution channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region
  • North America
    • The US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Nasal Drug Delivery Technology Market
2.2. Global Nasal Drug Delivery Technology Market, By Dosage form
2.3. Global Nasal Drug Delivery Technology Market, By Container Type
2.4. Global Nasal Drug Delivery Technology Market, By Therapeutic Application
2.5. Global Nasal Drug Delivery Technology Market, By Distribution Channel
2.6. Global Nasal Drug Delivery Technology Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Nasal Drug Delivery Technology Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Dosage form
3.5.2. Container Type
3.5.3. Therapeutic Application
3.5.4. Distribution Channel
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Dosage forms
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Dosage form Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Distribution Channel Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Nasal Drug Delivery Technology Market, By Dosage form
7.1. Global Nasal Drug Delivery Technology Market Overview, by Dosage form
7.1.1. Global Nasal Drug Delivery Technology Market Revenue Share, By Dosage form, 2022 Vs 2030 (in %)
7.2. Nasal Spray
7.2.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
7.3. Nasal Drop
7.3.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
7.4. Nasal Gel
7.4.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
7.5. Nasal Powder
7.5.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)

8. Global Nasal Drug Delivery Technology Market, By Container Type
8.1. Global Nasal Drug Delivery Technology Market Overview, by Container Type
8.1.1. Global Nasal Drug Delivery Technology Market, By Container Type, 2022 vs 2030 (in %)
8.2. Pressurized Containers
8.2.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
8.3. Non-pressurized Containers
8.3.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)

9. Global Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2030 (US$ Bn)
9.1. Global Nasal Drug Delivery Technology Market Overview, by Therapeutic Application
9.1.1. Global Nasal Drug Delivery Technology Market, By Therapeutic Application, 2022 vs 2030 (in%)
9.2. Nasal Congestion
9.2.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
9.3. Rhinitis
9.3.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
9.4. Asthma
9.4.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
9.5. Others
9.5.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)

10. Global Nasal Drug Delivery Technology Market, By Distribution Channel
10.1. Global Nasal Drug Delivery Technology Market Overview, by Distribution Channel
10.1.1. Global Nasal Drug Delivery Technology Market Revenue Share, By Distribution Channel, 2022 Vs 2030 (in %)
10.2. HOSPITAL PHARMACIES
10.2.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
10.3. Retail Pharmacies
10.3.1. Global Nasal Drug Delivery Technology Market, By Region, 2017-2030 (US$ Bn)
10.4. Online Pharmacies

11. Global Nasal Drug Delivery Technology Market, By Region
11.1. Global Nasal Drug Delivery Technology Market Overview, by Region
11.1.1. Global Nasal Drug Delivery Technology Market, By Region, 2022 vs 2030 (in%)
11.2. Dosage form
11.2.1. Global Nasal Drug Delivery Technology Market, By Dosage form, 2017-2030 (US$ Bn)
11.3. Container Type
11.3.1. Global Nasal Drug Delivery Technology Market, By Container Type, 2017-2030 (US$ Bn)
11.4. Therapeutic Application
11.4.1. Global Nasal Drug Delivery Technology Market, By Therapeutic Application, 2017-2030 (US$ Bn)
11.5. Distribution Channel
11.5.1. Global Nasal Drug Delivery Technology Market, By Therapeutic Application, 2017-2030 (US$ Bn)

12. North America Nasal Drug Delivery Technology Market Analysis
12.1. North America Nasal Drug Delivery Technology Market, by Dosage form, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. North America Nasal Drug Delivery Technology Market, by Container Type, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2030(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America Nasal Drug Delivery Technology Market, by Country, 2017-2030 (US$ Bn)
12.5.1. North America Nasal Drug Delivery Technology Market, by Country, 2022 Vs 2030 (in%)
12.5.2. U.S.
12.5.2.1. U.S. Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.2.2. U.S. Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
12.5.2.3. U.S. Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
12.5.2.4. U.S. Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
12.5.2.5. U.S. Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
12.5.3. Canada
12.5.3.1. Canada Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.3.2. Canada Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
12.5.3.3. Canada Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
12.5.3.4. Canada Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
12.5.3.5. Canada Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
12.5.4. Mexico
12.5.4.1. Mexico Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.4.2. Mexico Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
12.5.4.3. Mexico Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
12.5.4.4. Mexico Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
12.5.4.5. Mexico Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)

13. Europe Nasal Drug Delivery Technology Market Analysis
13.1. Europe Nasal Drug Delivery Technology Market, by Dosage form, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Europe Nasal Drug Delivery Technology Market, by Container Type, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2030(US$ Bn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe Nasal Drug Delivery Technology Market, by Country, 2017-2030 (US$ Bn)
13.5.1. Europe Nasal Drug Delivery Technology Market, by Country, 2022 Vs 2030 (in%)
13.5.2. Germany
13.5.2.1. Germany Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.2.2. Germany Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
13.5.2.3. Germany Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
13.5.2.4. Germany Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
13.5.2.5. Germany Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.3. France
13.5.3.1. France Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.3.2. France Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
13.5.3.3. France Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
13.5.3.4. France Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
13.5.3.5. France Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.4. UK
13.5.4.1. UK Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.4.2. UK Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
13.5.4.3. UK Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
13.5.4.4. UK Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
13.5.4.5. UK Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.5. Italy
13.5.5.1. Italy Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.5.2. Italy Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
13.5.5.3. Italy Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
13.5.5.4. Italy Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
13.5.5.5. Italy Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.6. Spain
13.5.6.1. Spain Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.6.2. Spain Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
13.5.6.3. Spain Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
13.5.6.4. Spain Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
13.5.6.5. Spain Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
13.5.7. Rest of Europe
13.5.7.1. Rest of Europe Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.7.2. Rest of Europe Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
13.5.7.3. Rest of Europe Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
13.5.7.4. Rest of Europe Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
13.5.7.5. Rest of Europe Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)

14. Asia Pacific Nasal Drug Delivery Technology Market Analysis
14.1. Asia Pacific Nasal Drug Delivery Technology Market, by Dosage form, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Asia Pacific Nasal Drug Delivery Technology Market, by Container Type, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2030(US$ Bn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific Nasal Drug Delivery Technology Market, by Country, 2017-2030 (US$ Bn)
14.5.1. Asia Pacific Nasal Drug Delivery Technology Market, by Country, 2022 Vs 2030 (in%)
14.5.2. China
14.5.2.1. China Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.2.2. China Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
14.5.2.3. China Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
14.5.2.4. China Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
14.5.2.5. China Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.3. Japan
14.5.3.1. Japan Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.3.2. Japan Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
14.5.3.3. Japan Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
14.5.3.4. Japan Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
14.5.3.5. Japan Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.4. India
14.5.4.1. India Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.4.2. India Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
14.5.4.3. India Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
14.5.4.4. India Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
14.5.4.5. India Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.5. South Korea
14.5.5.1. South Korea Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.5.2. South Korea Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
14.5.5.3. South Korea Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
14.5.5.4. South Korea Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
14.5.5.5. South Korea Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.6. South-East Asia
14.5.6.1. South-East Asia Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.6.2. South-East Asia Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
14.5.6.3. South-East Asia Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
14.5.6.4. South-East Asia Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
14.5.6.5. South East Asia Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
14.5.7. Rest of Asia Pacific
14.5.7.1. Rest of Asia Pacific Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.7.2. Rest of Asia Pacific Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
14.5.7.3. Rest of Asia Pacific Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
14.5.7.4. Rest of Asia Pacific Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
14.5.7.5. Rest of Asia Pacific Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)

15. Latin America Nasal Drug Delivery Technology Market Analysis
15.1. Latin America Nasal Drug Delivery Technology Market, by Dosage form, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Latin America Nasal Drug Delivery Technology Market, by Container Type, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2030(US$ Bn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America Nasal Drug Delivery Technology Market, by Country, 2017-2030 (US$ Bn)
15.5.1. Latin America Nasal Drug Delivery Technology Market, by Country, 2022 Vs 2030 (in%)
15.5.2. Brazil
15.5.2.1. Brazil Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.2.2. Brazil Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
15.5.2.3. Brazil Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
15.5.2.4. Brazil Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
15.5.2.5. Brazil Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
15.5.3. Argentina
15.5.3.1. Argentina Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.3.2. Argentina Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
15.5.3.3. Argentina Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
15.5.3.4. Argentina Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
15.5.3.5. Argentina Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
15.5.4. Rest of Latin America
15.5.4.1. Rest of Latin America Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.4.2. Rest of Latin America Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
15.5.4.3. Rest of Latin America Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
15.5.4.4. Rest of Latin America Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
15.5.4.5. Rest of Latin America Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)

16. Middle East and Africa Nasal Drug Delivery Technology Market Analysis
16.1. Middle East and Africa Nasal Drug Delivery Technology Market, by Dosage form, 2017-2030(US$ Bn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Middle East and Africa Nasal Drug Delivery Technology Market, by Container Type, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East and Africa Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East and Africa Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East and Africa Nasal Drug Delivery Technology Market, by Country, 2017-2030 (US$ Bn)
16.5.1. Middle East and Africa Nasal Drug Delivery Technology Market, by Country, 2022 Vs 2030 (in%)
16.5.2. GCC Countries
16.5.2.1. GCC Countries Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.2.2. GCC Countries Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
16.5.2.3. GCC Countries Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
16.5.2.4. GCC Countries Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
16.5.2.5. GCC Countries Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
16.5.3. South Africa
16.5.3.1. South Africa Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.3.2. South Africa Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
16.5.3.3. South Africa Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
16.5.3.4. South Africa Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
16.5.3.5. South Africa Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)
16.5.4. Rest of Middle East and Africa
16.5.4.1. Rest of Middle East and Africa Nasal Drug Delivery Technology Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.4.2. Rest of Middle East and Africa Nasal Drug Delivery Technology, By Dosage form, 2017-2030 (US$ Bn)
16.5.4.3. Rest of Middle East and Africa Nasal Drug Delivery Technology, By Container Type, 2017-2030 (US$ Bn)
16.5.4.4. Rest of Middle East and Africa Nasal Drug Delivery Technology, By Therapeutic Application, 2017-2030 (US$ Bn)
16.5.4.5. Rest of Middle East and Africa Nasal Drug Delivery Technology, By Distribution Channel, 2017-2030 (US$ Bn)

17. Company Profiles
17.1. GlaxoSmithKline PLC
17.1.1. Company Overview
17.1.2. Distribution Channels/Nasal Gels Portfolio
17.1.3. Geographical Presence
17.1.4. Financial Summary
17.1.4.1. Market Revenue and Net Profit (2019-2022)
17.1.4.2. Business Segment Revenue Analysis
17.1.4.3. Geographical Revenue Analysis
17.2. AstraZeneca PLC
17.3. Pfizer, Inc
17.4. OptiNose, Inc.
17.5. Becton, Dickinson and Company
17.6. Promius Pharma, LLC
17.7. Cadila Pharmaceuticals Ltd
17.8. B.F. Ascher & Company, Inc.
17.9. PendoPharm, Inc.
17.10. Douglas Pharmaceuticals Ltd.
17.11. ENT Technologies Pty. Ltd.
17.12. NAVEH Pharma Ltd.

List of Figures
FIG. 1 Global Nasal Drug Delivery Technology Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Nasal Drug Delivery Technology Market Segmentation
FIG. 4 Global Nasal Drug Delivery Technology Market, by Dosage form, 2022 (US$ Bn)
FIG. 5 Global Nasal Drug Delivery Technology Market, by Container Type, 2022 (US$ Bn)
FIG. 6 Global Nasal Drug Delivery Technology Market, by Therapeutic Application, 2022 (US$ Bn)
FIG. 7 Global Nasal Drug Delivery Technology Market, by Distribution Channel, 2022 (US$ Bn)
FIG. 8 Global Nasal Drug Delivery Technology Market, by Geography, 2022 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Dosage form, 2022
FIG. 10 Attractive Investment Proposition, by Container Type, 2022
FIG. 11 Attractive Investment Proposition, by Therapeutic Application, 2022
FIG. 12 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key Nasal Drug Delivery Technology Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key Nasal Drug Delivery Technology Market Manufacturers, 2022
FIG. 16 Global Nasal Drug Delivery Technology Market Value Contribution, By Dosage form, 2022 & 2030 (Value %)
FIG. 17 Global Nasal Drug Delivery Technology Market, by Nasal Spray, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Nasal Drug Delivery Technology Market, by Nasal Drop, Value, 2017-2030 (US$ Bn)
FIG. 19 Global Nasal Drug Delivery Technology Market, by Nasal Gel, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Nasal Drug Delivery Technology Market, by Nasal Powder, Value, 2017-2030 (US$ Bn)
FIG. 21 Global Nasal Drug Delivery Technology Market Value Contribution, By Container Type, 2022 & 2030 (Value %)
FIG. 22 Global Nasal Drug Delivery Technology Market, by Pressurized Containers, Value, 2017-2030 (US$ Bn)
FIG. 23 Global Nasal Drug Delivery Technology Market, by Non-pressurized Containers, 2017-2030 (US$ Bn)
FIG. 24 Global Nasal Drug Delivery Technology Market Value Contribution, By Therapeutic Application, 2022 & 2030 (Value %)
FIG. 25 Global Nasal Drug Delivery Technology Market, by Nasal Congestion, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Nasal Drug Delivery Technology Market, by Rhinitis, 2017-2030 (US$ Bn)
FIG. 27 Global Nasal Drug Delivery Technology Market, by Asthma, 2017-2030 (US$ Bn)
FIG. 28 Global Nasal Drug Delivery Technology Market, by Others, 2017-2030 (US$ Bn)
FIG. 29 Global Nasal Drug Delivery Technology Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 30 Global Nasal Drug Delivery Technology Market, by HOSPITAL PHARMACIES, Value, 2017-2030 (US$ Bn)
FIG. 31 Global Nasal Drug Delivery Technology Market, by Retail Pharmacies, 2017-2030 (US$ Bn)
FIG. 32 Global Nasal Drug Delivery Technology Market, by Online Pharmacies, 2017-2030 (US$ Bn)
FIG. 33 North America Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 34 U.S. Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 35 Canada Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 36 Europe Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 37 Germany Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 38 France Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 39 U.K. Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 40 Italy Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 41 Spain Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 42 Rest of Europe Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 43 Asia Pacific Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 44 China Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 45 Japan Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 46 India Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 47 South Korea Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 48 South-East Asia Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Asia Pacific Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 50 Latin America Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 51 Brazil Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 52 Mexico Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 53 Rest of Latin America Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 54 Middle East & Africa Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 55 GCC Countries Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 56 South Africa Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)
FIG. 57 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Nasal Drug Delivery Technology Market
TABLE 2 Global Nasal Drug Delivery Technology Market: Market Drivers Impact Analysis
TABLE 3 Global Nasal Drug Delivery Technology Market: Market Restraints Impact Analysis
TABLE 4 Global Nasal Drug Delivery Technology Market, by Competitive Benchmarking, 2022
TABLE 5 Global Nasal Drug Delivery Technology Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Nasal Drug Delivery Technology Market, by Key Strategies Analysis, 2022
TABLE 7 Global Nasal Drug Delivery Technology Market, by Nasal Spray, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Nasal Drug Delivery Technology Market, by Nasal Spray, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Nasal Drug Delivery Technology Market, by Nasal Drop, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Nasal Drug Delivery Technology Market, by Nasal Drop, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Nasal Drug Delivery Technology Market, by Nasal Gel, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Nasal Drug Delivery Technology Market, by Nasal Gel, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Nasal Drug Delivery Technology Market, by Nasal Powder, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Nasal Drug Delivery Technology Market, by Nasal Powder, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Nasal Drug Delivery Technology Market, by Pressurized Containers, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Nasal Drug Delivery Technology Market, by Pressurized Containers, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Nasal Drug Delivery Technology Market, by Non-pressurized Containers, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Nasal Drug Delivery Technology Market, by Non-pressurized Containers, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Nasal Drug Delivery Technology Market, by Nasal Congestion, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Nasal Drug Delivery Technology Market, by Nasal Congestion, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Nasal Drug Delivery Technology Market, by Rhinitis, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Nasal Drug Delivery Technology Market, by Rhinitis, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Nasal Drug Delivery Technology Market, by Asthma, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Nasal Drug Delivery Technology Market, by Asthma, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Nasal Drug Delivery Technology Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Nasal Drug Delivery Technology Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Nasal Drug Delivery Technology Market, by HOSPITAL PHARMACIES, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Nasal Drug Delivery Technology Market, by HOSPITAL PHARMACIES, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Nasal Drug Delivery Technology Market, by Retail Pharmacies, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Nasal Drug Delivery Technology Market, by Retail Pharmacies, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Nasal Drug Delivery Technology Market, by Online Pharmacies, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Nasal Drug Delivery Technology Market, by Online Pharmacies, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 34 Global Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 35 Global Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 36 Global Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 37 Global Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 38 Global Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 39 Global Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 40 Global Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 41 Global Nasal Drug Delivery Technology Market, by Region, 2017-2022 (US$ Bn)
TABLE 42 Global Nasal Drug Delivery Technology Market, by Region, 2023-2030 (US$ Bn)
TABLE 43 North America Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 44 North America Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 45 North America Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 46 North America Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 47 North America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 48 North America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 49 North America Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 50 North America Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 51 North America Nasal Drug Delivery Technology Market, by Country, 2017-2022 (US$ Bn)
TABLE 52 North America Nasal Drug Delivery Technology Market, by Country, 2023-2030 (US$ Bn)
TABLE 53 United States Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 54 United States Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 55 United States Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 56 United States Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 57 United States Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 58 United States Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 59 United States Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 60 United States Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 61 Canada Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 62 Canada Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 63 Canada Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 64 Canada Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 65 Canada Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 66 Canada Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 67 Canada Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 68 Canada Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 69 Mexico Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 70 Mexico Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 71 Mexico Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 72 Mexico Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 73 Mexico Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 74 Mexico Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 75 Mexico Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 76 Mexico Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 77 Europe Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 78 Europe Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 79 Europe Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 80 Europe Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 81 Europe Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 82 Europe Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 83 Europe Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 84 Europe Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 85 Europe Nasal Drug Delivery Technology Market, by Country, 2017-2022 (US$ Bn)
TABLE 86 Europe Nasal Drug Delivery Technology Market, by Country, 2023-2030 (US$ Bn)
TABLE 87 Germany Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 88 Germany Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 89 Germany Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 90 Germany Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 91 Germany Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 92 Germany Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 93 Germany Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 94 Germany Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 95 France Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 96 France Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 97 France Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 98 France Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 99 France Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 100 France Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 101 France Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 102 France Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 103 United Kingdom Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 104 United Kingdom Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 105 United Kingdom Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 106 United Kingdom Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 107 United Kingdom Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 108 United Kingdom Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 109 United Kingdom Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 110 United Kingdom Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 111 Italy Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 112 Italy Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 113 Italy Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 114 Italy Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 115 Italy Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 116 Italy Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 117 Italy Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 118 Italy Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 119 Spain Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 120 Spain Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 121 Spain Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 122 Spain Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 123 Spain Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 124 Spain Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 125 Spain Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 126 Spain Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 127 Rest of Europe Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 128 Rest of Europe Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 129 Rest of Europe Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 130 Rest of Europe Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 131 Rest of Europe Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 132 Rest of Europe Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 133 Rest of Europe Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 134 Rest of Europe Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 135 Asia Pacific Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 136 Asia Pacific Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 137 Asia Pacific Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 138 Asia Pacific Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 139 Asia Pacific Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 140 Asia Pacific Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 141 Asia Pacific Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 142 Asia Pacific Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 143 China Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 144 China Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 145 China Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 146 China Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 147 China Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 148 China Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 149 China Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 150 China Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 151 Japan Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 152 Japan Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 153 Japan Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 154 Japan Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 155 Japan Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 156 Japan Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 157 Japan Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 158 Japan Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 159 India Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 160 India Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 161 India Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 162 India Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 163 India Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 164 India Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 165 India Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 166 India Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 167 South Korea Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 168 South Korea Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 169 South Korea Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 170 South Korea Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 171 South Korea Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 172 South Korea Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 173 South Korea Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 174 South Korea Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 175 South-East Asia Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 176 South-East Asia Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 177 South-East Asia Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 178 South-East Asia Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 179 South-East Asia Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 180 South-East Asia Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 181 South East Asia Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 182 South East Asia Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 183 Rest of Asia Pacific Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 184 Rest of Asia Pacific Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 185 Rest of Asia Pacific Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 186 Rest of Asia Pacific Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 187 Rest of Asia Pacific Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 188 Rest of Asia Pacific Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 189 Rest of Asia Pacific Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 190 Rest of Asia Pacific Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 191 Latin America Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 192 Latin America Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 193 Latin America Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 194 Latin America Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 195 Latin America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 196 Latin America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 197 Latin America Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 198 Latin America Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 199 Brazil Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 200 Brazil Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 201 Brazil Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 202 Brazil Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 203 Brazil Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 204 Brazil Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 205 Brazil Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 206 Brazil Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 207 Argentina Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 208 Argentina Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 209 Argentina Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 210 Argentina Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 211 Argentina Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 212 Argentina Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 213 Argentina Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 214 Argentina Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 215 Rest of Latin America Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 216 Rest of Latin America Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 217 Rest of Latin America Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 218 Rest of Latin America Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 219 Rest of Latin America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 220 Rest of Latin America Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 221 Rest of Latin America Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 222 Rest of Latin America Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 223 Middle East and Africa Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 224 Middle East and Africa Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 225 Middle East and Africa Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 226 Middle East and Africa Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 227 Middle East and Africa Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 228 Middle East and Africa Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 229 Middle East and Africa Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 230 Middle East and Africa Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 231 GCC Countries Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 232 GCC Countries Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 233 GCC Countries Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 234 GCC Countries Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 235 GCC Countries Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 236 GCC Countries Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 237 GCC Countries Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 238 GCC Countries Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 239 South Africa Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 240 South Africa Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 241 South Africa Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 242 South Africa Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 243 South Africa Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 244 South Africa Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 245 South Africa Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 246 South Africa Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 247 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, by Dosage form, 2017-2022 (US$ Bn)
TABLE 248 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, by Dosage form, 2023-2030 (US$ Bn)
TABLE 249 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, by Container Type, 2017-2022 (US$ Bn)
TABLE 250 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, by Container Type, 2023-2030 (US$ Bn)
TABLE 251 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, by Therapeutic Application, 2017-2022 (US$ Bn)
TABLE 252 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, by Therapeutic Application, 2023-2030 (US$ Bn)
TABLE 253 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 254 Rest of Middle East and Africa Nasal Drug Delivery Technology Market, by Distribution Channel, 2023-2030 (US$ Bn)

Frequently Asked Questions:

What is the current size of the global nasal drug delivery technology market?

The global nasal drug delivery technology market was valued at USD 72.5 Billion in 2022.

What is the expected growth rate of the nasal drug delivery technology market between 2023 and 2030?

The nasal drug delivery technology market is expected to grow at a CAGR of 7.90% between 2023 and 2030, reaching USD 123.4 Billion in 2030.

Which segment is leading the market share in terms of dosage form?

Nasal spray is the leading segment by dosage form, holding over 43% share in terms of value in 2022.

Which segment is leading the market share in terms of container-type outlooks?

Non-pressurized containers are the leading segment by container type, holding over 43% share in terms of value in 2022.

Which therapeutic application segment globally governs the demand for nasal drug delivery technology?

Rhinitis segment governs the demand for nasal drug delivery technology in the world, holding a massive share of over 80% in 2022.

Which segment is expected to post the highest CAGR during the forecast period?

The retail pharmacies segment is expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the nasal drug delivery technology industry?

North America is fueling the growth of the nasal drug delivery technology industry, with an over one-third share in 2022.

Who are the major players in the global nasal drug delivery technology market?

The top players include GlaxoSmithKline PLC; AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson, and Company; Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company, Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; NAVEH Pharma Ltd.

What are the major market drivers of the nasal drug delivery technology industry?

The rising prevalence of chronic diseases and the increasing inclination for an alternate drug administration method that provides improved patient comfort are the major market drivers.

What are the major market restraints of the nasal drug delivery technology industry?

The major market restraints are histopathological toxicity or a smaller absorption region than orally delivered drugs.

What are the major market opportunities of the nasal drug delivery technology industry?

Technological developments and the introduction of sophisticated nasal medication delivery devices are the major opportunities in the technology industry.

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

Pediatric Bladder Treatment Market

Published:
Report ID: 33540

Neurotrophic Keratitis Treatment Market

Published:
Report ID: 33425

Precision Medicine Market

Published:
Report ID: 11123

Eosinophilic Pneumonia Treatment Market

Published:
Report ID: 5486

Myelodysplastic Syndrome Market

Published:
Report ID: 32821

US Retail Pharmacy Market

Published:
Report ID: 32801

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN